GUTS Q2 2024 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

GUTSFractyl Health, Inc. Common Stock

$35M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$43,000-40.3% YoY

Gross Profit

$19,00044.2% margin

Operating Income

-$23M-53453.5% margin

Net Income

-$17M-40067.4% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

+30.3%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$146M

Total Liabilities

$76M

Stockholders' Equity

$71M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43,000	$72,000	-40.3%
Gross Profit	$19,000	$25,000	-24.0%
Operating Income	-$23M	-$12M	-93.6%
Net Income	-$17M	-$30M	+43.0%